TY - JOUR
T1 - Bone formation during distraction osteogenesis is dependent on both VEGFR1 and VEGFR2 signaling
AU - Jacobsen, Kimberly A.
AU - Al-Aql, Zainab S.
AU - Wan, Chao
AU - Fitch, Jennifer L.
AU - Stapleton, Stephanie N.
AU - Mason, Zachary D.
AU - Cole, Robert M.
AU - Gilbert, Shawn R.
AU - Clemens, Thomas L.
AU - Morgan, Elise F.
AU - Einhorn, Thomas A.
AU - Gerstenfeld, Louis C.
PY - 2008/5
Y1 - 2008/5
N2 - Introduction: Distraction osteogenesis (DO) is characterized by the induction of highly vascularized new bone formation through an intramembranous process largely devoid of the formation of cartilage. Materials and Methods: To test the hypothesis that DO is strictly dependent on vascualrization, we inhibited vascular endothelial growth factor (VEGF) activity by antibody blockade of both receptors VEGFR1 (Flt-1) and VEGFR2 (Flk-1) or only VEGFR2 (Flk-1) in a previously developed murine tibia DO model. During normal DO, VEGFR1 (Flt-1), VEGFR2 (Flk-1), VEGFR3 (Flt4) and all four VEGF ligand (A, B, C, and D) mRNAs are induced. Results: The expression of mRNA for the receptors generally paralleled those of the ligands during the period of active distraction. Bone formation, as assessed by μCT, showed a significant decrease with the double antibody treatment and a smaller decrease with single antibody treatment. Vessel volume, number, and connectivity showed progressive and significant inhibition in all of these of parameters between the single and double antibody blockade. Molecular analysis showed significant inhibition in skeletal cell development with the single and double antibody blockade of both VEGFR1 and 2. Interestingly, the single antibody treatment led to selective early development of chondrogenesis, whereas the double antibody treatment led to a failure of both osteogenesis and chondrogenesis. Conclusions: Both VEGFR1 and VEGFR2 are functionally essential in blood vessel and bone formation during DO and are needed to promote osteogenic over chondrogenic lineage progression.
AB - Introduction: Distraction osteogenesis (DO) is characterized by the induction of highly vascularized new bone formation through an intramembranous process largely devoid of the formation of cartilage. Materials and Methods: To test the hypothesis that DO is strictly dependent on vascualrization, we inhibited vascular endothelial growth factor (VEGF) activity by antibody blockade of both receptors VEGFR1 (Flt-1) and VEGFR2 (Flk-1) or only VEGFR2 (Flk-1) in a previously developed murine tibia DO model. During normal DO, VEGFR1 (Flt-1), VEGFR2 (Flk-1), VEGFR3 (Flt4) and all four VEGF ligand (A, B, C, and D) mRNAs are induced. Results: The expression of mRNA for the receptors generally paralleled those of the ligands during the period of active distraction. Bone formation, as assessed by μCT, showed a significant decrease with the double antibody treatment and a smaller decrease with single antibody treatment. Vessel volume, number, and connectivity showed progressive and significant inhibition in all of these of parameters between the single and double antibody blockade. Molecular analysis showed significant inhibition in skeletal cell development with the single and double antibody blockade of both VEGFR1 and 2. Interestingly, the single antibody treatment led to selective early development of chondrogenesis, whereas the double antibody treatment led to a failure of both osteogenesis and chondrogenesis. Conclusions: Both VEGFR1 and VEGFR2 are functionally essential in blood vessel and bone formation during DO and are needed to promote osteogenic over chondrogenic lineage progression.
KW - Angiogenesis
KW - Bone morphogenetic protein
KW - Distraction osteogenesis
KW - Vascular endothelial growth factor
KW - Vascular endothelial growth factor receptors
UR - http://www.scopus.com/inward/record.url?scp=42449132519&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=42449132519&partnerID=8YFLogxK
U2 - 10.1359/jbmr.080103
DO - 10.1359/jbmr.080103
M3 - Article
C2 - 18433297
AN - SCOPUS:42449132519
SN - 0884-0431
VL - 23
SP - 596
EP - 609
JO - Journal of Bone and Mineral Research
JF - Journal of Bone and Mineral Research
IS - 5
ER -